期刊文献+

慢性丙型肝炎患者HCV准种变异研究 被引量:2

Study on the change of HCV quasispecies in patients with chronic hepatitis C
下载PDF
导出
摘要 目的研究慢性丙型肝炎患者体内准种的多样性及动态变化过程,探讨其与病程进展的关系及感染慢性化的原因。方法应用异源双链泳动技术(HMA)研究在干扰素治疗压力下慢性丙型肝炎患者体内准种的变化。结果慢性HCV患者无论对干扰素应答情况如何,其体内HCV准种的数量没有明显变化,但无应答者体内HCV准种的异质性发生了明显改变;治疗前占支配地位的准种株群在不同感染者体内的比例并不相同,随着抗病毒治疗的进行,不断有新的异质性程度更高的准种株出现,打破原有的平衡比例。结论慢性HCV患者对干扰素治疗有无应答,取决于变异株的异质性程度,而不是变异株数量。在干扰素治疗压力下,原来宿主与病毒之间的平衡已经被打破,耐药的准种株被选择出来,占据支配地位,是导致感染持续存在的原因之一。 Objective To investigate the quasispecies diversity and the dynamics of quasispecies heterogeneity of hepatitis C viruses in patients with chronic hepatitis C. Methods Dynamic changes of HCV quasispecies before and after IFN therapy were detected by heteroduplex mobility assay(HMA) .Results No change in viral complexity was observed with therapy, but there were markedly changes in viral divergence. The proportion of major pretreatment variants was different in HVR1 in all patients. During the treatment, HCV quasispecies changed significantly. Conclusion Responsiveness to interferon may be related to the changes in viral divergence, but not related to the numbers of viral variants.
作者 穆锦江 祁勇
出处 《哈尔滨医科大学学报》 CAS 北大核心 2008年第1期75-77,共3页 Journal of Harbin Medical University
基金 黑龙江省自然科学基金资助项目(D2004-47)
关键词 丙型肝炎病毒 准种 异源双链泳动分析 HCV quasispecies heteroduplex mobihty assay
  • 相关文献

参考文献5

  • 1Eisen-Vandervelde AL, Yao ZQ, Hahn YS. The molecular basis of HCV-mediated immune dysregulation [ J ]. Clin Immunol, 2004, 111 (1) : 16-21. 被引量:1
  • 2Gaud U, Langer B, Petropoulou T, et al. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects [ J ]. J Med Viral, 2003,69 (3) : 350-356. 被引量:1
  • 3Alfonso V, Flichman DM, Sookoian S, et al. Evolutionary study of HVR1 of E2 in chrome hepatitis C vires infection[J]. J Gen Virol, 2004,85(1) :39-46. 被引量:1
  • 4Sumpter R Jr, Wang C, Foy E, et al. Viral evolution and interferon resistance of hepatitis C virus RNA replication in a cell culture model [J] .J Virol,2004,78(21 ) : 11591-11604. 被引量:1
  • 5Chambers T J, Fan X, Droll DA, et al. Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection[J] .J Virol,2005,79(5) : 3071-3083. 被引量:1

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部